RecruitingNot ApplicableNCT05177679
Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption
Sponsor
University of Illinois at Urbana-Champaign
Enrollment
288 participants
Start Date
Jun 23, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to test the casual relationship between carotenoid supplementation, cognitive function, and achievement over a school-year. The central hypothesis is that, relative to the waitlist placebo group, children receiving the carotenoid supplement will exhibit greater gains in cognitive function and achievement.
Eligibility
Min Age: 8 YearsMax Age: 10 Years
Inclusion Criteria6
- Child assent and parent/guardian consent
- years of age
- No lutein supplementation within 6-months prior to enrollment (exception of multivitamins containing less than 1 mg lutein/day)
- Absence of learning disability (parent-reported)
- Tanner scale score ≤ 2
- /20 or corrected vision
Exclusion Criteria6
- Non-assent of child or non-consent of guardian
- Above/below 8-10 years of age
- Lutein supplementation within 6-months prior to enrollment (including multivitamins containing more than 1 mg lutein/day)
- Identified learning disability (parent-reported)
- Tanner scale score \> 2
- Not 20/20 or uncorrected vision
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTActive supplement
Carotenoid supplement comprised of 10mg lutein and 2mg zeaxanthin.
DIETARY_SUPPLEMENTPlacebo control
Placebo control supplement
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05177679
Related Trials
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
NCT071252091 location
Exercise to Improve Brain Health in Older African Americans
NCT055971241 location
Impact of Indoor Overheating on Physiological Strain in Children
NCT072612021 location
Heat Stress in Individuals With Schizophrenia
NCT073833241 location
Amplitude Titration to Improve ECT Clinical Outcomes
NCT056992261 location